References

Abramson, S.B. and G. Weissmann, 1989. The mechan-isms of action of nonsteroidal anti-inflammatory drugs. Arthritis Rheum., 32: 1-9.
PubMed  |  

Barnes, J.C. and M. Lee, 1998. Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli miii mouse model with aspirin. Gastroenterology, 114: 873-877.
PubMed  |  

Duflois, R.N. and W.E. Smalley, 1996. Cyclooxygenase, NSAJDs and colorectal cancer (Review). J. Gastroenterol., 31: 898-906.
PubMed  |  

Giardiello, F.M., S.R. Hamilton, A.J. Krush, S. Piantadosi, L.M. Hylind et al., 1993. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med., 328: 1313-1316.
PubMed  |  

Kutchera, W., D.A. Jones and N. Matsunami, 1996. Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: Evidence for a transcriptional effect. Proc. Natl. Acad. Sci. USA., 93: 4816-4820.
PubMed  |  

Meade, E.A., W.L. Smith and D.L. DeWitt, 1993. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem., 268: 6610-6614.
PubMed  |  

Moorghen, M., P. Ince, K.J. Finney, J.P. Sunter, D.R. Appleton and A.J. Watson, 1988. A protective effect of sulindac against chemically-induced primary colonic tumours in mice. J. Pathol., 156: 341-347.
PubMed  |  

Pereira, M.A., L.H. Barmes, V.E. Steele, G.V. Kellof and R.A. Lubert, 1996. Piroxicam induced regression of azoxymethane-induced aberrant crypt foci and prevention of colon cancer in rats. Carcinogenesis, 17: 373-376.
PubMed  |  

Piazza, G.A., D.S. Alberts and U. Hixson, 1997. Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. Cancer Res., 57: 2909-2915.
PubMed  |  

Pollard, M. and P.H. Luckert, 1981. Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitrosamine. Science, 214: 558-559.
PubMed  |  

Pollard, M. and P.H. Luckert, 1989. Prevention and treatment of primary intestinal tumors in rats by piroxicam. Cancer Res., 49: 6471-6473.
PubMed  |  

Quesada, C.F., H. Kimata, M. Mon, M. Nishimura, T. Tsuneyoshi and S. Baba, 1998. Piroxicam and acarbose as chemopreventive agents for spontaneous intestinal adenomas in APC gene 1309 knockout mice. Jap. J. Cancer Res., 89: 392-396.
PubMed  |  

Smith, M.L., G. Hawcroft and M.A. Hull, 2000. The effect of nonsteroidal antiinflammatory drugs on human colorectal cancer cells: Evidence of different mechanism of action. Eur. J. Cancer, 36: 664-674.
PubMed  |  

Somchit, N., H. Siti-Musalmah and S. Suraiya-Hani, 2002. Itraconazole-and fluconazole-induced toxicity in rat hepatocytes: A comparative in vitro study. Hum. Exp. Toxicol., 21: 43-48.
CrossRef  |  PubMed  |  Direct Link  |  

Thun, M.J., M.M. Namboodiri and C. Heath, 1991. Aspirin use and reduced risk: Fatal colon cancer. Cancer Res., 53: 1322-1327.
PubMed  |  

Waddell, W.R., 1998. Stimulation of apoptosis by sulindac and piroxicam. Clin. Sci., 95: 385-388.
PubMed  |  

Weiss, H., A. Amberger, M. Widschwendter, R. Margreiter, D. Ofner and P. Dietl, 2001. Inhibition of store-operated calcium entry contributes to the anti-proliferative effect of nonsteroidal anti-inflammatory in human colon cancer cells. Int. J. Cancer, 92: 877-882.
PubMed  |  

Weiss, I.I.A. and D. Forman, 1996. Aspirin, NSAIDs and protection from colorectal cancer: A review of the epidemiological evidence. Scand. J. Gastroenterol. Rev., 220: 137-141.
PubMed  |